Stockscreener 앱 받기
8.59
1.90%
0.16
시간 외 거래:
8.59
전일 마감가:
$8.43
열려 있는:
$8.44
하루 거래량:
108.34K
Relative Volume:
0.69
시가총액:
$321.84M
수익:
$128.45M
순이익/손실:
$6.54M
주가수익비율:
171.80
EPS:
0.05
순현금흐름:
$-8.79M
1주 성능:
+6.05%
1개월 성능:
+5.14%
6개월 성능:
+15.46%
1년 성능:
+33.59%
1일 변동 폭
$8.40
$8.75
1주일 범위
$7.95
$8.75
52주 변동 폭
$4.76
$8.85
Lifecore Biomedical Inc Stock (LFCR) Company Profile
명칭
Lifecore Biomedical Inc
전화
(952) 368-4300
주소
3515 LYMAN BOULEVARD, CHASKA
LFCR을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
LFCR
Lifecore Biomedical Inc
|
8.59 | 315.84M | 128.45M | 6.54M | -8.79M | 0.05 |
|
ZTS
Zoetis Inc
|
124.40 | 55.12B | 9.40B | 2.65B | 2.24B | 5.935 |
|
TAK
Takeda Pharmaceutical Co Adr
|
15.94 | 50.80B | 29.63B | 260.53M | 5.51B | 0.0788 |
|
HLN
Haleon Plc Adr
|
10.33 | 45.60B | 14.26B | 1.98B | 2.47B | 0.4327 |
|
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
31.66 | 36.04B | 16.88B | 666.71M | 251.19M | 0.6132 |
|
UTHR
United Therapeutics Corp
|
472.06 | 20.23B | 3.08B | 1.24B | 1.07B | 25.61 |
Lifecore Biomedical Inc Stock (LFCR) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-09-04 | 개시 | KeyBanc Capital Markets | Sector Weight |
| 2025-05-21 | 개시 | William Blair | Outperform |
| 2024-09-05 | 개시 | Craig Hallum | Buy |
| 2024-08-28 | 다운그레이드 | Barrington Research | Outperform → Mkt Perform |
| 2023-03-20 | 다운그레이드 | Stephens | Overweight → Equal-Weight |
Lifecore Biomedical Inc 주식(LFCR)의 최신 뉴스
Notice to Long-Term Shareholders of CoreWeave, Inc. - GlobeNewswire
Lifecore Biomedical, Inc.'s (NASDAQ:LFCR) Subdued P/S Might Signal An Opportunity - simplywall.st
Attention Long-Term Shareholders of Ibotta, Inc. (NYSE: - GlobeNewswire
2026-01-18 | Lifecore Biomedical, Inc. (LFCR) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Shareholders to Contact the Firm to Learn More About the Investigation | NDAQ:LFCR | Press Release - Stockhouse
(LFCR) Risk Channels and Responsive Allocation - Stock Traders Daily
Lifecore Investors Ink $3.8M Deal In Accounting Controls Suit - Law360
Lifecore Biomedical Adopts New Performance-Based Incentive Bonus Plan - TipRanks
Lifecore Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - GlobeNewswire
What Contributes to Lifecore Biomedical’s (LFCR) Distinct Competitive Advantage? - Insider Monkey
Townhall - FinancialContent
Halper Sadeh LLC Encourages Lifecore Biomedical, Inc. Shareholders to Contact the Firm to Discuss Their Rights - Business Wire
Attention Long-Term Shareholders of Integer Holdings Corp, - GlobeNewswire
Lifecore Biomedical: Wins Should Blow Previous 'New Business' Estimates Out Of The Water (undefined:LFCR) - Seeking Alpha
Notice to Long-Term Shareholders of Lifecore Biomedical, Inc. (LFCR): Grabar Law Office Investigates Claims on Your Behalf as Securities Fraud Class Action Settles - TMX Newsfile
Bronstein, Gewirtz & Grossman, LLC Encourages Lifecore Biomedical, Inc. (LFCR) Stockholders to Inquire about Securities Investigation - ACCESS Newswire
Important Notice to Long-Term Shareholders of Integer Holdings Corp, (NYSE: ITGR); Lifecore Biomedical, Inc. (NASDAQ: LFCR); Molina Healthcare, Inc. (NYSE: MOH); and WEBTOON Entertainment Inc. (NASDAQ: WBTN): Grabar Law Office Investigates Clai - GlobeNewswire
Whittier Daily News - FinancialContent
Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against Lifecore Biomedical, Inc. (LFCR) And Encourages Stockholders to Reach Out - ACCESS Newswire
Insider Trends: Why Lifecore Biomedical Inc stock could rally in 20252025 Risk Factors & Stepwise Trade Signal Guides - Bộ Nội Vụ
Aug Selloffs: Why Lifecore Biomedical Inc. stock attracts high net worth investors2025 Market Sentiment & Stock Market Timing Techniques - Улправда
Pullback Watch: Can Lifecore Biomedical Inc. (LDE) stock deliver strong annual returnsJuly 2025 Closing Moves & Technical Buy Zone Confirmations - ulpravda.ru
Important Notice to Long-Term Shareholders of Integer Holdings Corp, (NYSE: ITGR); Lifecore Biomedical, Inc. (NASDAQ: LFCR); Molina Healthcare, Inc. (NYSE: MOH); and Synopsys, Inc. (NASDAQ: SNPS): Grabar Law Office Investigates Claims on Your Beh - GlobeNewswire
About Us - FinancialContent
Why Lifecore Biomedical Inc. stock attracts high net worth investorsDividend Hike & Low Volatility Stock Recommendations - Улправда
Is Lifecore Biomedical Inc. stock dividend yield sustainableWeekly Market Report & Daily Stock Trend Watchlist - Улправда
Why Lifecore Biomedical Inc. stock could rally in 2025July 2025 Volume & Risk Adjusted Buy and Sell Alerts - Улправда
How institutional buying supports Lifecore Biomedical Inc. stock2025 Support & Resistance & Real-Time Chart Breakout Alerts - Улправда
Notice to Long-Term Shareholders of Lifecore Biomedical, Inc. (LFCR): Grabar Law Office Investigates Claims on Your Behalf as Securities Fraud Class Action Reaches Settlement - TMX Newsfile
Why Lifecore Biomedical Inc. stock is a must watch in 2025Market Activity Recap & Weekly Setup with ROI Potential - Улправда
Activity Recap: Why Lifecore Biomedical Inc. stock is a must watch in 2025Trade Exit Report & Reliable Breakout Forecasts - ulpravda.ru
Will Lifecore Biomedical Inc. stock gain from lower inflationJuly 2025 Opening Moves & Long Hold Capital Preservation Tips - Улправда
Important Notice to Long-Term Shareholders of Cytokinetics, - GlobeNewswire
Published on: 2026-01-07 20:37:50 - Улправда
MSN Money - MSN
Notice to Long-Term Shareholders of Cytokinetics, Inc. (NASDAQ: CYTK); Lifecore Biomedical, ... - Bluefield Daily Telegraph
Notice to Long-Term Shareholders of Cytokinetics, Inc. - GlobeNewswire
KeyBanc says momentum, strategic value building at Lifecore - MSN
Operating cash flow per share of Lifecore Biomedical, Inc. – DUS:LDE - TradingView — Track All Markets
How sustainable is Lifecore Biomedical Inc. stock dividend payout2026 world cup usa national team semifinals defensive leaders set piece tactics knockout prediction expert opinion - Улправда
2026-01-06 | Lifecore Biomedical, Inc. (LFCR) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Stockholders to Contact the Firm to Learn More About the Investigation | NDAQ:LFCR | Press Release - Stockhouse
Lifecore Biomedical (LFCR) Reports Q1 Loss, Beats Revenue Estimates - MSN
(LFCR) Movement as an Input in Quant Signal Sets - Stock Traders Daily
Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Lifecore Biomedical, Inc. (LFCR) and Encourages Stockholders to Learn More About the Investigation - ACCESS Newswire
Important Notice to Long-Term Shareholders of CarMax, Inc. - GlobeNewswire
Press Telegram - FinancialContent
2026-01-04 | Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Lifecore Biomedical, Inc. (LFCR) and Encourages Stockholders to Learn More About the Investigation | NDAQ:LFCR | Press Release - Stockhouse
Lifecore Biomedical (NASDAQ:LFCR) Upgraded at Zacks Research - Defense World
Can IDBI Bank Limited Rally Enough to Break EvenRelative Strength Index (RSI) & Big Gains Small Budget - earlytimes.in
Analysts Offer Insights on Healthcare Companies: Outlook Therapeutics (OTLK) and Lifecore Biomedical (LFCR) - The Globe and Mail
Lifecore Biomedical: The Turnaround Is Just Getting Started (NASDAQ:LFCR) - Seeking Alpha
Important Notice to Long-Term Shareholders of CarMax, Inc. (NYSE: KMX); Inspire Medical Systems, Inc. (NYSE: INSP); Integer Holdings Corp. (NYSE: ITGR); Lifecore Biomedical, Inc. (NASDAQ: LFCR): Grabar Law Office Investigates Claims on Your Behalf - GlobeNewswire
Lifecore Biomedical Inc (LFCR) 재무 분석
매출
순이익
현금흐름
주당 순 이익
Lifecore Biomedical Inc 주식 (LFCR) 내부자 거래
| 내부자 거래 | 관계 | 날짜 | 거래 | 비용 | #주식 | 가치 ($) | #주식 총계 |
|---|---|---|---|---|---|---|---|
| English Aron R. | 10% Owner |
May 28 '25 |
Sale |
7.12 |
150,419 |
1,071,555 |
264,180 |
| English Aron R. | 10% Owner |
May 23 '25 |
Sale |
6.75 |
96,137 |
649,386 |
1,554,103 |
| English Aron R. | 10% Owner |
May 13 '25 |
Sale |
7.00 |
12,334 |
86,353 |
1,650,240 |
| English Aron R. | 10% Owner |
May 12 '25 |
Sale |
7.03 |
45,698 |
321,426 |
1,662,574 |
| English Aron R. | 10% Owner |
May 08 '25 |
Sale |
7.00 |
5,098 |
35,693 |
1,708,972 |
| English Aron R. | 10% Owner |
May 09 '25 |
Sale |
7.00 |
700 |
4,900 |
1,708,272 |
| English Aron R. | 10% Owner |
May 05 '25 |
Sale |
7.08 |
24,543 |
173,831 |
1,730,618 |
| English Aron R. | 10% Owner |
May 07 '25 |
Sale |
7.01 |
15,847 |
111,099 |
1,714,070 |
| English Aron R. | 10% Owner |
May 06 '25 |
Sale |
7.05 |
701 |
4,940 |
1,729,917 |
3.24%
자본화:
|
볼륨(24시간):